Richard K. Freeman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Richard K. Freeman has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Anthony J. Ascioti
14 shared publicationsAmy Vyverberg
7 shared publicationsJaclyn M. Van Woerkom
6 shared publicationsRaja J. Mahidhara
3 shared publicationsTheresa Giannini
2 shared publicationsThomas C. Wozniak
2 shared publications
Latest Publications
- 1 July 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (1) , 259-264
A Propensity-Matched Comparison of Pleurodesis or Tunneled Pleural Catheter in Patients Undergoing Diagnostic Thoracoscopy for Malignancy
- 1 July 2013
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 96 (1) , 259-264
A Propensity-Matched Comparison of Pleurodesis or Tunneled Pleural Catheter in Patients Undergoing Diagnostic Thoracoscopy for Malignancy
- 1 January 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (1) , 68-74
A comparison of quality and cost indicators by surgical specialty for lobectomy of the lung
- 1 January 2013
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 145 (1) , 68-74
A comparison of quality and cost indicators by surgical specialty for lobectomy of the lung
- 1 October 2012
- Published by Elsevier in Surgical Clinics of North America
- Vol. 92 (5) , 1337-1351
Palliative Therapy for Patients with Unresectable Esophageal Carcinoma
- 1 October 2012
- Published by Elsevier in Surgical Clinics of North America
- Vol. 92 (5) , 1337-1351
Palliative Therapy for Patients with Unresectable Esophageal Carcinoma
- 1 September 2012
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 94 (3) , 959-965
Analysis of Unsuccessful Esophageal Stent Placements for Esophageal Perforation, Fistula, or Anastomotic Leak
- 1 September 2012
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 94 (3) , 959-965
Analysis of Unsuccessful Esophageal Stent Placements for Esophageal Perforation, Fistula, or Anastomotic Leak
- 1 October 2011
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (4) , 1239-1243
The Effect of a Multidisciplinary Thoracic Malignancy Conference on the Treatment of Patients With Esophageal Cancer
- 1 October 2011
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (4) , 1239-1243
The Effect of a Multidisciplinary Thoracic Malignancy Conference on the Treatment of Patients With Esophageal Cancer
- 30 September 2011
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (3) , 1018-1023
Long-Term Follow-Up After Robotic Thymectomy for Nonthymomatous Myasthenia Gravis
- 30 September 2011
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (3) , 1018-1023
Long-Term Follow-Up After Robotic Thymectomy for Nonthymomatous Myasthenia Gravis
- 1 July 2011
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (1) , 204-208
Esophageal Stent Placement for the Treatment of Acute Intrathoracic Anastomotic Leak After Esophagectomy
- 1 July 2011
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 92 (1) , 204-208
Esophageal Stent Placement for the Treatment of Acute Intrathoracic Anastomotic Leak After Esophagectomy
- 1 June 2011
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 23 (2) , 154-158
Esophageal Stent Placement for the Treatment of Perforation, Fistula, or Anastomotic Leak
- 1 June 2011
- Published by Elsevier in Seminars in Thoracic and Cardiovascular Surgery
- Vol. 23 (2) , 154-158
Esophageal Stent Placement for the Treatment of Perforation, Fistula, or Anastomotic Leak
- 1 November 2010
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 90 (5) , 1681
Invited Commentary
- 1 November 2010
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 90 (5) , 1681
Invited Commentary
- 1 July 2010
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 38 (1) , 1-5
The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer☆
There is a paucity of data evaluating whether a multidisciplinary conference coordinating surgery, chemotherapy and radiation therapy translates into better patient care. This article compares the experiences of patients with lung cancer before and after the formation of a prospective, multidisciplinary thoracic malignancy care conference (TMC). The records of patients with a non-small-cell lung cancer at a tertiary care hospital were reviewed for completeness of staging, multidisciplinary evaluation prior to the initiation of therapy, time from pathologic diagnosis to treatment, multimodality therapy and adherence to national treatment guidelines. The summary data of patients treated before and after the TMC were initiated, and then compared. Between 2001 and 2007, 535 patients were treated prior to the initiation of the TMC and 687 patients within the TMC. The number of patients receiving a complete staging evaluation (79%/93%: p<0.0001), multidisciplinary evaluation prior to therapy (62%/96%: p<0.0001) and adherence to the National Comprehensive Cancer Network (NCCN) treatment guidelines (81%/97%: p<0.0001) all increased significantly while mean days from diagnosis to treatment significantly decreased (29/17: p<0.0001) following the initiation of a TMC. A multidisciplinary thoracic malignancy conference increased the percentage of patients receiving complete staging, a multidisciplinary evaluation and adherence to nationally accepted care guidelines while decreasing the interval from diagnosis to treatment significantly. While the ultimate goal of treatment is to improve patient survival, the surrogate variables examined in this review indicate that patients with non-small-cell lung cancer benefit from being evaluated in a prospective, multidisciplinary care conference.
- 1 July 2010
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 38 (1) , 1-5
The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer☆
There is a paucity of data evaluating whether a multidisciplinary conference coordinating surgery, chemotherapy and radiation therapy translates into better patient care. This article compares the experiences of patients with lung cancer before and after the formation of a prospective, multidisciplinary thoracic malignancy care conference (TMC). The records of patients with a non-small-cell lung cancer at a tertiary care hospital were reviewed for completeness of staging, multidisciplinary evaluation prior to the initiation of therapy, time from pathologic diagnosis to treatment, multimodality therapy and adherence to national treatment guidelines. The summary data of patients treated before and after the TMC were initiated, and then compared. Between 2001 and 2007, 535 patients were treated prior to the initiation of the TMC and 687 patients within the TMC. The number of patients receiving a complete staging evaluation (79%/93%: p<0.0001), multidisciplinary evaluation prior to therapy (62%/96%: p<0.0001) and adherence to the National Comprehensive Cancer Network (NCCN) treatment guidelines (81%/97%: p<0.0001) all increased significantly while mean days from diagnosis to treatment significantly decreased (29/17: p<0.0001) following the initiation of a TMC. A multidisciplinary thoracic malignancy conference increased the percentage of patients receiving complete staging, a multidisciplinary evaluation and adherence to nationally accepted care guidelines while decreasing the interval from diagnosis to treatment significantly. While the ultimate goal of treatment is to improve patient survival, the surrogate variables examined in this review indicate that patients with non-small-cell lung cancer benefit from being evaluated in a prospective, multidisciplinary care conference.